Abstract:Hypoxia is a common characteristic of solid tumors. This important feature is associated with resistance to radio-chemotherapy, which results in poor prognosis and probability of tumor recurrence. Taking advantage of background-free NIR II fluorescence imaging and deeper-penetrating photoacoustic (PA) imaging, we developed a hypoxia-triggered and nitroreductase (NTR) enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy (PTT), which will overcome cellular resistance during hypoxia. Methods: The single molecule probe IR1048-MZ was synthesized by conjugating a nitro imidazole group as a specific hypoxia trigger with an IR-1048 dye as a NIR II/PA signal reporter. We investigated the NIR II fluorescence, NIR absorbance and photothermal effect in different hypoxia conditions in vitro, and performed NIR II/PA tumor imaging and hypoxia-activated photothermal therapy in mice. Results: This versatile molecular probe IR1048-MZ not only realized high-contrast tumor visualization with a clear boundary by NIR II fluorescence imaging, but also afforded deep-tissue penetration at the centimeter level by 3D PA imaging. Moreover, after being activated by NTR that is overexpressed in hypoxic tumors, the probe exhibited a significant photothermal effect for curative tumor ablation with no recurrence. Conclusions: We have developed the first hypoxia-triggered and NTR enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy. By tracing the activity of NTR, IR1048-MZ may be a promising contrast agent and theranostic formulation for other hypoxia-related diseases (such as cancer, inflammation, stroke, and cardiac ischemia).

Advanced deep-tissue imaging and manipulation enabled by biliverdin reductase knockout.

Deep-tissue photoacoustic imaging of photoswitchable transgenic mouse models

iLight2: A near‐infrared optogenetic tool for gene transcription with low background activation

Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging

Developing A Bright Nir-Ii Fluorophore With Fast Renal Excretion And Its Application In Molecular Imaging Of Immune Checkpoint Pd-L1

Multiscale Photoacoustic Tomography of a Genetically Encoded Near‐Infrared FRET Biosensor

An optimized bioluminescent substrate for non-invasive imaging in the brain

Highly bright and stable NIR-BRET with blue-shifted coelenterazine derivatives for deep-tissue imaging of molecular events in vivo

A luciferase prosubstrate and a red bioluminescent calcium indicator for imaging neuronal activity in mice

“Crossbreeding” Small-Molecular Weight NIR-II Flavchromenes Endows Activatable Multiplexed in Vivo Imaging

Self-Assembling Endogenous Biliverdin as a Versatile Near-Infrared Photothermal Nanoagent for Cancer Theranostics

Biocompatible Near-Infrared Fluorescent Nanoparticles for Macro and Microscopic in Vivo Functional Bioimaging.

Imaging bioluminescence by detecting localized haemodynamic contrast from photosensitized vasculature

In Vivo Assembly and Disassembly of Probes to Improve Near‐Infrared Optical Bioimaging

Advanced NIR ratiometric probes for intravital biomedical imaging

Rational Design of an Activatable Near‐Infrared Fluorogenic Platform for In Vivo Orthotopic Tumor Imaging and Resection

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

Photostimulable Near-Infrared Persistent Luminescent Nanoprobes for Ultrasensitive and Longitudinal Deep-Tissue Bio-Imaging.

NIR-II Self-Luminous Molecular Probe for In Vivo Inflammation Tracking and Cancer PDT Effect Self-Evaluating

Engineered Amber-Emitting Nano Luciferase and Its Use for Immunobioluminescence Imaging In Vivo

Brightening up Biology: Advances in Luciferase Systems for in Vivo Imaging